Sales and adj. EBITDA -2% and -7% vs. ABGSCe +3,000 customer intake q-o-q vs.
Redeye’s comments on the Q2 report that was published earlier this morning.
Pihlajalinna reports Q2 results on Fri, Aug 12. Q2 earnings will remain modest due to the integratio...
Redeye updates its estimates following Careium’s Q2’22 report, which was more or less inline with th...
NoHo Partners reported Q2 EBIT of EUR 16.1m, +18% versus Refinitiv consensus and +2% versus Nordea.
Redeye provides a preview ahead of Embracers Q1’22/23 report due on 18th August.
Q2 estimates down on lower production from the Tie field Drilling campaign to commence in Oman fro...
Rovio will publish its Q2 report on 11 August at 9:00 EET.
Redeye leaves its view on Xspray following friday's Q2 report, where it announced a vision of genera...
Scanfil’s Q2 report didn’t reveal big surprises, although there were a couple of profitability headw...
Safe at Sea tillverkar sök- och livräddningsbåtar för SAR-verksamhet (Search and Rescue).
Relais issued a profit warning and pre-released Q2 numbers this morning.
We raise our full-year group clean EBIT forecast by ~50%.
Revenue growth was in line with expectations but operating profit was 10% lower than Refinitiv conse...
Redeye considers BIMobject’s figures to be overall in line with our expectations, but mainly driven ...
EAB reported H1 comparable operating income of EUR 14.
Redeye is positive about the work done by Moberg Pharma to further strengthen their partner network ...
CapMan showed good progress across the board in Q2.
Scanfil’s Q2 report didn’t serve any major surprises.
Isofol Medical announced that the phase III trial AGENT had failed to reach its primary and most imp...
